Global Canine Arthritis Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 14-Jul-2021
No. of pages: 100
Inquire Before Buying

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine's fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.

Market Analysis and Insights: Global Canine Arthritis Treatment Market

The global Canine Arthritis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Arthritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Arthritis Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Arthritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Arthritis Treatment market.

Global Canine Arthritis Treatment Scope and Market Size

Canine Arthritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Canine Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Non-Steroidal Anti-Inflammatory Drugs

- Opioids

Segment by Application

- Veterinary Hospitals and Clinics

- Drug Stores

- E-commerce

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Elanco (Eli Lilly and Company)

- Boehringer Ingelheim

- Zoetis Inc

- Vetoquinol S.A.

- Bayer AG

- Aratana Therapeutics Inc

- Norbrook Laboratories Limited

- VetStem Biopharma

- Dechra Pharmaceuticals Plc

Global Canine Arthritis Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Canine Arthritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Drug Stores
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Treatment Market Perspective (2016-2027)
2.2 Canine Arthritis Treatment Growth Trends by Regions
2.2.1 Canine Arthritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Canine Arthritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Canine Arthritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Canine Arthritis Treatment Industry Dynamic
2.3.1 Canine Arthritis Treatment Market Trends
2.3.2 Canine Arthritis Treatment Market Drivers
2.3.3 Canine Arthritis Treatment Market Challenges
2.3.4 Canine Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Treatment Players by Revenue
3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue
3.4 Global Canine Arthritis Treatment Market Concentration Ratio
3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2020
3.5 Canine Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Canine Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Canine Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Treatment Breakdown Data by Type
4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2022-2027)
5 Canine Arthritis Treatment Breakdown Data by Application
5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Canine Arthritis Treatment Market Size (2016-2027)
6.2 North America Canine Arthritis Treatment Market Size by Type
6.2.1 North America Canine Arthritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Canine Arthritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Canine Arthritis Treatment Market Size by Type (2016-2027)
6.3 North America Canine Arthritis Treatment Market Size by Application
6.3.1 North America Canine Arthritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Canine Arthritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Canine Arthritis Treatment Market Size by Application (2016-2027)
6.4 North America Canine Arthritis Treatment Market Size by Country
6.4.1 North America Canine Arthritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Canine Arthritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size (2016-2027)
7.2 Europe Canine Arthritis Treatment Market Size by Type
7.2.1 Europe Canine Arthritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Canine Arthritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Canine Arthritis Treatment Market Size by Type (2016-2027)
7.3 Europe Canine Arthritis Treatment Market Size by Application
7.3.1 Europe Canine Arthritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Canine Arthritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Canine Arthritis Treatment Market Size by Application (2016-2027)
7.4 Europe Canine Arthritis Treatment Market Size by Country
7.4.1 Europe Canine Arthritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Canine Arthritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Canine Arthritis Treatment Market Size by Type
8.2.1 Asia-Pacific Canine Arthritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Canine Arthritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Canine Arthritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Application
8.3.1 Asia-Pacific Canine Arthritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Canine Arthritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Canine Arthritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Canine Arthritis Treatment Market Size by Region
8.4.1 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Canine Arthritis Treatment Market Size (2016-2027)
9.2 Latin America Canine Arthritis Treatment Market Size by Type
9.2.1 Latin America Canine Arthritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Canine Arthritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Canine Arthritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Canine Arthritis Treatment Market Size by Application
9.3.1 Latin America Canine Arthritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Canine Arthritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Canine Arthritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Canine Arthritis Treatment Market Size by Country
9.4.1 Latin America Canine Arthritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Canine Arthritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Canine Arthritis Treatment Market Size by Type
10.2.1 Middle East & Africa Canine Arthritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Canine Arthritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Canine Arthritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Application
10.3.1 Middle East & Africa Canine Arthritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Canine Arthritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Canine Arthritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Canine Arthritis Treatment Market Size by Country
10.4.1 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco (Eli Lilly and Company)
11.1.1 Elanco (Eli Lilly and Company) Company Details
11.1.2 Elanco (Eli Lilly and Company) Business Overview
11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction
11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2016-2021)
11.1.5 Elanco (Eli Lilly and Company) Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Details
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction
11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2016-2021)
11.3.5 Zoetis Inc Recent Development
11.4 Vetoquinol S.A.
11.4.1 Vetoquinol S.A. Company Details
11.4.2 Vetoquinol S.A. Business Overview
11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction
11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2016-2021)
11.4.5 Vetoquinol S.A. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Canine Arthritis Treatment Introduction
11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Aratana Therapeutics Inc
11.6.1 Aratana Therapeutics Inc Company Details
11.6.2 Aratana Therapeutics Inc Business Overview
11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction
11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2016-2021)
11.6.5 Aratana Therapeutics Inc Recent Development
11.7 Norbrook Laboratories Limited
11.7.1 Norbrook Laboratories Limited Company Details
11.7.2 Norbrook Laboratories Limited Business Overview
11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction
11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2016-2021)
11.7.5 Norbrook Laboratories Limited Recent Development
11.8 VetStem Biopharma
11.8.1 VetStem Biopharma Company Details
11.8.2 VetStem Biopharma Business Overview
11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction
11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2016-2021)
11.8.5 VetStem Biopharma Recent Development
11.9 Dechra Pharmaceuticals Plc
11.9.1 Dechra Pharmaceuticals Plc Company Details
11.9.2 Dechra Pharmaceuticals Plc Business Overview
11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction
11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2016-2021)
11.9.5 Dechra Pharmaceuticals Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Global Canine Arthritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Canine Arthritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Canine Arthritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Canine Arthritis Treatment Market Share by Regions (2016-2021)
Table 8. Global Canine Arthritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Canine Arthritis Treatment Market Share by Regions (2022-2027)
Table 10. Canine Arthritis Treatment Market Trends
Table 11. Canine Arthritis Treatment Market Drivers
Table 12. Canine Arthritis Treatment Market Challenges
Table 13. Canine Arthritis Treatment Market Restraints
Table 14. Global Canine Arthritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Canine Arthritis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Arthritis Treatment as of 2020)
Table 17. Ranking of Global Top Canine Arthritis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Canine Arthritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Canine Arthritis Treatment Product Solution and Service
Table 21. Date of Enter into Canine Arthritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Canine Arthritis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Canine Arthritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Canine Arthritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Canine Arthritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Canine Arthritis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Canine Arthritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Canine Arthritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Canine Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Canine Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Canine Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Canine Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Canine Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Canine Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Canine Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Canine Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Canine Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Canine Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Canine Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Canine Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Canine Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Canine Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Canine Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Canine Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Canine Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Canine Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Canine Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Canine Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Canine Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Canine Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Elanco (Eli Lilly and Company) Company Details
Table 62. Elanco (Eli Lilly and Company) Business Overview
Table 63. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product
Table 64. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 65. Elanco (Eli Lilly and Company) Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Canine Arthritis Treatment Product
Table 69. Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Zoetis Inc Company Details
Table 72. Zoetis Inc Business Overview
Table 73. Zoetis Inc Canine Arthritis Treatment Product
Table 74. Zoetis Inc Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 75. Zoetis Inc Recent Development
Table 76. Vetoquinol S.A. Company Details
Table 77. Vetoquinol S.A. Business Overview
Table 78. Vetoquinol S.A. Canine Arthritis Treatment Product
Table 79. Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 80. Vetoquinol S.A. Recent Development
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Canine Arthritis Treatment Product
Table 84. Bayer AG Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. Aratana Therapeutics Inc Company Details
Table 87. Aratana Therapeutics Inc Business Overview
Table 88. Aratana Therapeutics Inc Canine Arthritis Treatment Product
Table 89. Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 90. Aratana Therapeutics Inc Recent Development
Table 91. Norbrook Laboratories Limited Company Details
Table 92. Norbrook Laboratories Limited Business Overview
Table 93. Norbrook Laboratories Limited Canine Arthritis Treatment Product
Table 94. Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 95. Norbrook Laboratories Limited Recent Development
Table 96. VetStem Biopharma Company Details
Table 97. VetStem Biopharma Business Overview
Table 98. VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 99. VetStem Biopharma Recent Development
Table 100. Dechra Pharmaceuticals Plc Company Details
Table 101. Dechra Pharmaceuticals Plc Business Overview
Table 102. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product
Table 103. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 104. Dechra Pharmaceuticals Plc Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 3. Opioids Features
Figure 4. Global Canine Arthritis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Veterinary Hospitals and Clinics Case Studies
Figure 6. Drug Stores Case Studies
Figure 7. E-commerce Case Studies
Figure 8. Canine Arthritis Treatment Report Years Considered
Figure 9. Global Canine Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Canine Arthritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Canine Arthritis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Canine Arthritis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Canine Arthritis Treatment Market Share by Players in 2020
Figure 14. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Arthritis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Canine Arthritis Treatment Revenue in 2020
Figure 16. Global Canine Arthritis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Canine Arthritis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Canine Arthritis Treatment Market Share by Type (2016-2027)
Figure 20. North America Canine Arthritis Treatment Market Share by Application (2016-2027)
Figure 21. North America Canine Arthritis Treatment Market Share by Country (2016-2027)
Figure 22. United States Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Canine Arthritis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Canine Arthritis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Canine Arthritis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Canine Arthritis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Canine Arthritis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2016-2027)
Figure 38. China Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Canine Arthritis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Canine Arthritis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Canine Arthritis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Canine Arthritis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Canine Arthritis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Canine Arthritis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Canine Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 59. Zoetis Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 60. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 62. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 63. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 64. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 65. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs